Motor neuron axonal excitability changes in the clinical course of amyotrophic lateral sclerosis
Neurological Sciences · 2025
DOI: 10.1007/s10072-025-08443-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Panagiotis Kokotis und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Aigineition" Hospital, Athens, Greece. pkokotis@m…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neurons, Axons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Athens.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by slowly progressive degeneration of upper motor neurons (UMNs) and lower motor neurons (LMNs). Although the pathogenesis of sporadic form of ALS has not been fully elucidated, the initial damage mostly leads to hyperexcitability of the central and peripheral motor neuron. The results of our study aimed to confirm the changes in the excitability of the peripheral motor axon and contribute to the emergence of these measurements as potential biomarkers for disease progression. A total of 56 ALS patients [24 women (43%), median age 62.5 (interquartile range: 53.75–70.25) years] were finally included in the study. Twenty-four healthy controls that were age- and sex-matched to the cases [12 women (50%), mean age 58.46 ± 8.84] were recruited. The first main finding of our study is the fact that abnormalities of the voltage gated K + ion channels were constantly present in ALS patients than in the controls. The multivariate analysis revealed that Superexcitability 7ms lower than − 21.06%, related to shorter survival. Additionally using receiver operating characteristic (ROC) curves, the c-statistic showed Superexcitability 7ms moderate predictive ability. The clinical significance of our results is that Superexcitability 7ms can be used as a biomarker not only for survival but also for disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Aigineition" Hospital, Athens, Greece. pkokotis@med.uoa.gr.
- Second Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.
- Mannheim Medical School, Department of Anesthesiology Ethics approval, University of Heidelberg, Mannheim, Germany.
- First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Aigineition" Hospital, Athens, Greece.
Förderung
- University of Athens
Zitieren
APA
Kokotis, P., Bakola, E., Schmelz, M., Rentzos, M., Papagiannopoupou, G., & Tsivgoulis, G. (2025). Motor neuron axonal excitability changes in the clinical course of amyotrophic lateral sclerosis. Neurological Sciences. https://doi.org/10.1007/s10072-025-08443-w
Vancouver
Kokotis P, Bakola E, Schmelz M, Rentzos M, Papagiannopoupou G, Tsivgoulis G. Motor neuron axonal excitability changes in the clinical course of amyotrophic lateral sclerosis. Neurological Sciences. 2025. doi:10.1007/s10072-025-08443-w
BibTeX
@article{Kokotis2025,
author = {Kokotis, Panagiotis and Bakola, Eleni and Schmelz, Martin and Rentzos, Michalis and Papagiannopoupou, Georgia and Tsivgoulis, Georgios},
title = {Motor neuron axonal excitability changes in the clinical course of amyotrophic lateral sclerosis},
journal = {Neurological Sciences},
year = {2025},
doi = {10.1007/s10072-025-08443-w}
}
EUVIMED